7th Annual Genome Editing US CongressJune 2021 | Boston, USA

With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.

The NextGen Omics Series US includes...

Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.

Last Year's Agenda at a Glance

Day One

  • Genome Editing Technologies & Techniques
  • Drug Discovery & Development Applications in In Vivo Therapeutics

Day Two

  • Drug Discovery & Development – Target Identification and Validation
  • Non-Human Models in Diagnostics & Therapeutics

Live Webinar

FluidFM: a new approach
to CRISPR gene editing

Thursday, Mar 19 2020 | 1:00 PM - 2:00 PM GMT

hosted by Dr. Paul Monnier, Field Application Scientist
& Dr. Maria Milla, Life Sciences Application Scientist

Live Webinar

Higher Quality Nucleic Acid Extraction from FFPE Tissue & Other Challenging Samples Using the Ionic™ Purification System

hosted by Klint Rose, Chief Scientific Officer, Purigen Biosystems

Wednesday 27th May
16:00 BST